Use www.AirNow.gov
AirNow.gov has been moved to www.AirNow.gov You will be redirected automatically.
Related Articles
Study Highlights Global Trends in Risk Factors Linked to Lung Cancer Deaths – InventUM
A new study by Sylvester researchers used trends in tracheal, bronchial and lung cancer deaths to emphasize the need for policy vigilance.
Study by Sylvester, Collaborators Highlights Global Trends in Risk Factors Linked to Lung Cancer Deaths | Newswise
Lung and related cancer deaths decreased in the world’s 10 most populous countries over the past 40 years, but there is still a pressing need…
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response
Key PointsAdding navitoclax to ongoing ruxolitinib demonstrates durable responses and potential disease modification in relapsed/refractory MF.Thrombocytop
Elon Musk Sets His Sights on Toppling Another World Leader
Not satisfied with what he’s done to America, the world’s richest man is now looking to interfere in a European country.
At least 5 dead as thousands flee raging wildfires in Los Angeles area: Live updates | CNN
Massive wind-driven fires in Los Angeles County have killed at least five people and left others with “significant injuries.” Follow for live updates.
Higher Aircraft Noise Exposure Is Linked to Worse Heart Structure and Function by Cardiovascular MRI:
AbstractBackgroundAircraft noise is a growing concern for communities living near airports.ObjectivesThis study aimed to explore the impact of aircraft noise on heart structure and function.Methods…
Adjuvant Immunotherapy Should Not be Used in Patients With a Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy
Immunotherapies, specifically monoclonal antibodies targeting the programmed death–1 and programmed death-ligand 1 axis, have rapidly become integral in the management of most patients with early-stage…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
Oncology-focused Postdoctoral Training In Care Delivery and Symptom
Funded by a National Cancer Institute research training grant (1T32CA275764-01A1), the Oncology-focused Postdoctoral Training In Care Delivery and Symptom Science (OPTICS) Training Program at Memorial…
The current landscape of frontline large B-cell lymphoma trials
Since the addition of rituximab to CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), major advances in first-line therapy of large B-cell
